Categories

Tag: Quality

PODCAST/PHYSICIANS/QUALITY: Interview with David Seligman, CEO of Best Doctors

Here’s the transcript of the interview earlier this week with David Seligman, CEO of Best Doctors. Pretty interesting especially for those of you thinking about how to improve health care quality on a national and perhaps nationally branded level. (By the way, the transcriptionists at Castingwords are getting really quick! They only got this 36 hours ago). For those of you who prefer listening to reading the audio is here.

Matthew Holt:  This is Matthew Holt. I’m here with The Health Care Blog, and I’m talking with David Seligman. David is the CEO of Best Doctors, based in Boston, Massachusetts, and is also a locational contributor to the Boston Globe, as I noticed the other day‑‑and I’ve just found out, a regular reader of The Health Care Blog, which always is a pleasing thing.

David Seligman:  [laughs]

Matthew:  David, good morning. How are you?

David:  Good morning, absolutely, Matthew. I enjoyed being with you down at the World Health Care Congress, and I understand you’re going to be there again this year.

Matthew:  I’ll be looking forward to it. Anybody that’s listening can come by. I’ll be doing some blogging from there all three days.

David:  Excellent.

Matthew:  Let’s start with the real basics. I know that Best Doctors is a referral service and a second opinion service, and it’s obviously a lot more than that, but that’s, I believe, what it is at its core. For those readers of The Health Care Blog who are a bit more casual, can you just give the basic introduction to what you do, what problem you’re solving, and how you solve it?

David:  Yes, absolutely. Best Doctors is a global organization located with a presence in 30 countries around the world. It was originated by physicians from Harvard Medical School in the late 80s. What these physicians were seeing were many patients coming from around the US, and from other countries, to the Boston area, in search of the best information or the best medical care. They realized, back in the late 80s, that nine out of 10 of these patients could’ve, should’ve, stayed home with their local providers. Again, what they were looking for was what they thought would be access to better a quality of care and treatment. What we pioneered was a database of 50,000 of the world’s leading physicians in over 420 sub‑specialties of medicine. We tap into these physicians to really help us provide a comprehensive clinical review of serious or complex medical cases, and we really identify a correct diagnosis or course of treatment over 60 percent of the times in the cases that we’re doing, particularly here in the US. Once again, Best Doctors, we’re a global resource‑‑a trusted resource‑‑to help people with serious illnesses access the best medical care, without having to leave their local physician or local environment.

Continue reading…

PODCAST/PHYSICIANS/QUALITY: Interview with David Seligman, CEO of Best Doctors

This is an interesting podcast (well aren’t they all?). I interviewed the CEO of Best Doctors, David Seligman, about his network of second opinion providers and a whole lot more. They’re having quite a bit of success selling the service, which essentially is a combination of a medical advocacy service, expert review, and second and third opinion service for people with major medical problems. They already have on the way to $40m in revenues, 50,000 doctors on the list, and a significant number of employer and insurer clients.  Are they a model for the future of high end acute and even chronic care management? Well listen in and see.

TECH/QUALITY: Stents–it’s even worse than we thought, WITH UPDATE from The Industry Veteran

Note: I put this up late last night–but it’s such a huge story (and as one emailer says, can you think of a recent study that so blatantly points out all the flaws in the health care industry better than this?) that I’ve moved it to the top today

Man. This is no fun for Boston Scientific and the rest. Most angioplasties unneeded, study finds. This is even worse than was thought. Non-emergency angioplasties with stents are not even any good at reducing chest pain (angina) compared to drugs over 5 years:

The stunning results found that angioplasty did not save lives or prevent heart attacks in non-emergency heart patients. An even bigger surprise: Angioplasty gave only slight and temporary relief from chest pain, the main reason it is done. "By five years, there was really no significant difference" in symptoms, said Dr. William Boden of Buffalo General Hospital in New York. "Few would have expected such results."

<SNIP>

About 1.2 million angioplasties are done in the United States each year. Through a blood vessel in the groin, doctors snake a tube to a blocked heart artery. A tiny balloon is inflated to flatten the clog and a mesh scaffold stent is usually placed. The procedure already has lost some popularity because of emerging evidence that popular drug-coated stents can raise the risk of blood clots months later. The new study shifts the argument from which type of stent to use to whether to do the procedure at all. It involved 2,287 patients throughout the U.S. and Canada who had substantial blockages, typically in two arteries, but were medically stable. They had an average of 10 chest pain episodes a week — moderately severe. About 40 percent had a prior heart attack.

Live by the stent and potentially die by it. BSX was down around 6% at the close. And it would be un-THCB like to say “I told you so”, but I told you so.

UPDATE: Meanwhile, all the analysts MarketWatch polled don’t think that this study will make any difference, even though BSX barely got a dead-cat bounce today after its mauling yesterday. And then, well you knew this was coming….here’s what The Industry Veteran thinks about my pussyfooting around the issue:

The NEJM study on stents versus medical therapy, publicized this week in connection with the American College of Cardiology meeting, is not really “worse than what we thought” in terms of what it reveals about the larger health care system. It demonstrates exactly what we thought and what I’ve made explicit on this site several times. Ed Silverman over at Pharmalot nails it squarely when he writes that a large segment of cardiologists feel threatened by the study’s results because there are financial incentives for them to insert stents. In other words, the big problems facing health care will not be adequately addressed by digitalizing medical records, adopting treatment algorithms or any other technical tweaks. As long as the public remains hostage to obsessively greedy manufacturers, equally greedy physicians and third-party payers that are capital aggregators, we will continue to pay more than the rest of the world for our health care and, for the population as a whole, derive fewer benefits. Too many middlemen are allowed to extract too much economic rent from the health care system.

As the ACC meeting in New Orleans winds down, I’m reminded of a conversation I had at a previous meeting with a cardiologist from Westchester County, New York. American society, in his considered opinion, must guarantee practitioners who choose to start in his field a minimum yearly salary of $250,000 in return for their willingness to “give up the decade of their twenties.” Until then I still held the naive notion that while nationally acclaimed investigators working in academic medicine are exalted whores and crooks, the garden variety specialists in solo offices maintain genuine concerns for their patients as they work to obtain a secure but not unconscionable livelihood. In a pig’s eye!! Specialty practice in the United States today attracts people with the souls of Tony Soprano or “Chainsaw” Al Dunlop and it refines their predatory instincts through an arduous indoctrination process. Debating whether they or the pharma and stent companies do more to corrupt the system remains pointless, similar to arguing whether local politicians or the road contractors who bribe them are worse crooks.

QUALITY: Plantar warts, duct tape and the real cure

David Williams at Health Business Blog pokes some fun at some investigators looking into a cure for plantar warts who used the wrong type of duct tape in trying to figure out if this cure works. (He calls it File this in the “What were they thinking category?”).

However, having had one of those miserable bastards (a wart that generates it’s own dang blood supply) and failed to get rid of it in the conventional way (acid that  kills the rest of the skin on the foot but not the plantar wart) I know the answer. It’s this stuff. http://www.amoils.com/warts.html Works exactly as advertised. This is the only medical product I’ve ever endorsed, and no they’re not paying me and don’t know about this posting! (OK, so it’s an “n” of one, but these guys are still in business 4 years later….)

HOSPITALS/POLICY/QUALITY: Harvard Business Professor #2 doesn’t understand economics

Today, following yesterdays lashing out at Reggie, the next Harvard Prof who’s been teeing me off is Michael Porter (and his Virginia colleague Elizabeth Teisberg).

I’d been meaning to comment on Michael Porter’s latest piece in JAMA (not that I get to read it being too cheap to subscribe), but I did see the write-up in The Boston Globe and I have read the book he wrote with Elizabeth Teisbgerg. Now even if Teisberg was somehow unable to be interviewed about it after her PR agent initially hunted me down (She wasn’t concerned that she couldn’t defend her ideas, per chance? Elizabeth, my podcast offer is still open!), it has made many otherwise sensible people go gaga. Apparently Porter gets $100K a day for showing up for hospital consulting gigs and McKinsey did a straight copy and paste of his ideas for one of their articles recently (and it costs a lot more than $100K for them to show up!)

Now to be fair the first chapter of their book has the most thorough review of what’s wrong with American health care that I’ve ever seen. I’ve always assumed that if you are a big-shot Professor at Harvard or Virginia you get the best research assistants that graduate stipends can buy, and that chapter certainly proves me out.

But as I said three years ago when he was talking about it, Porter is quite correct to say that many improvements could be made in health care. The problem, he says, is that we’re competing about the wrong things. He wants to change all that by appealing to providers to do it better.

Most proposals to overhaul US healthcare systems — including
extending insurance to all Americans — address the "margins" of the
problem, Porter said. Doctors, he added, must lead the effort to help
create "a system where everyone is rewarded for value." For
example, a patient undergoing treatment for breast cancer typically has
to make repeat appointments with different doctors and specialists on
different days. Under his model, Porter said, the same patient should
be able to walk into one building and meet various specialists on the
same day, and those specialists should immediately consult with one
another.Then, he said, the hospital should closely follow its
cases, tracking survival rates, recovery times, and patient
satisfaction, among other things.

Well this is brilliant new thinking. OK, so Codman came up with that last part about tracking quality measures over 90 years ago, and some other guy has been harping on about it for a while too. But now Porter’s on the case it’s bound to happen, and even though Codman’s grave and Berwick’s shop are a short cab ride away, why expect him not to reinvent that wheel? After all he’s not the innovator guy (more on Christensen coming later on THCB).

Unfortunately the same thing is true for that team approach centered around the patient. Kaiser Permanente has been talking about it (and possibly even doing it) for years. Even Bernie Salick was doing something like that in his cancer centers by attempting to build all the activity around the patients’ need. And they are by no means the only examples. But that was back in the 1980s. Obviously because Michael Porter brings this up now it’s a great new idea.

Or just maybe there’s another reason why this approach hasn’t happened. Perhaps, no one’s been prepared to use the power of money to enforce it on the medical establishment.

Because if you do use the power of money, they will respond in a highly market-driven fashion. And there’s a great example of this response in the very same issue of JAMA in which Porter’s words of wisdom are printed. Over at The Doctor Weighs In, Pat Salber gives an excellent explanation of the case in point which is is the rash of one-stop heart hospitals that opened in the late 1990s and early 2000s.

These seem to be the incarnation of what Porter and (lord save us) Reggie Herzlinger are talking about. Dedicated one-stop consumer friendly, high efficiency focused-factories that treat only one disease very well, and give a complete ranges of services centered around that consumer. But of course one minor, teeny issue, is that heart procedures are still more or less paid for an a fee-per-episode basis.

So what does the data tell us? You know the answer, but let me have Pat Salber tell you anyway:

Of course, it is possible that new specialty hospitals would just
compete with existing facilities in general hospitals, taking volume
from them, but keeping the overall rates of services the same. But that
doesn’t appear to be what happens when one of these cardiac specialty
hospitals opens in a community. Instead, the JAMA study documents that
there is an incremental increase in the number of coronary
revascularization procedures performed after a specialty heart hospital
opens. Capacity increases and more people get these procedures.

So unless we change the incentives behind the system, any new fangled way of doing things (team work, new dedicated focused-factories patient-friendly clinics, etc, etc) will be used by the system to provide more stuff to the same number of people and to charge more overall money.

The team work, the new processes, the new procedures, etc, all that good stuff Porter (and the rest of us) want to see more of will emerge as a result of incentives. Right now there aren’t really any incentives to provide care in a cost-effective and patient friendly way, which is why the outliers that Michael Porter wants everyone else to turn into are just that–outliers.

None of this stuff has any relevance to mainstream provider groups which essentially face economic suicide if they adopt any of his more extreme approaches–such as specializing in only one type of condition and competing nationally versus locally. What’s even more worrying is that that seems to be exactly what McKinsey is recommending.

Instead we currently have a market which is the result of a set of incentives that encourages more to be done. More to be done, it must be noted, in the absence of any evidence that more needs to be done, but in a market where cardiologists have a strong demand for second homes and newer Porsches. Hence the current mess with specialty heart hospitals. (And imaging centers, overuse of chemo drugs community oncologists, spine surgeons doing too many fusions, etc, etc… the list goes on).

What we need is to change the incentive system so that somebody (consumers, their agents, the government, someone) gets to make a rational choice about the right level to pay per unit of care as compared to other ways to get value from that marginal dollar. And the "unit" should be not the cost of a single procedure, nor a bundle of services for particular illnesses, but the average cost of care for a population over time. If there was real competition over dollars between agents/plans/aggregators/integrated systems (call them what you like) to provide the best answer to that conundrum — and people could walk with their attached dollars, vouchers, whatever, to the competition if they were doing it better — then you would see all the innovations, team work and Kaizen processes that you want.

That’s how it works in other markets. But those other markets don’t have the complication of third-party coverage which is essential to spread costs of the huge disparity in needs for care.

But that’s not where the health care market is now, and we’re a damn long way from it going there, and instead the money is flowing in the wrong place for the wrong things–as Porter points out. Getting there of course requires a political change because it requires fundamentally changing the entire insurance system, moving to universal coverage, instituting a visible or hidden set of subsidies, and doing a raft of other stuff that Alain Enthoven and others have been calling for since 1975 (or before). And they know how difficult that is.

According to Porter "Most proposals to overhaul US healthcare systems — including
extending insurance to all Americans — address the "margins" of the
problem".
How is that the "margins of the problem". It IS the damn problem and if it were sorted out all the things Porter’s talking about would more or less take care of themselves. 

I guess being a mere business school professor Porter just doesn’t have the economics background to understand why incentives matter so much in health care. On the other hand, if he can become millionaire from a mere 10 days work consulting in the field, then perhaps he does?

HEALTH PLANS/QUALITY: Setting up high performance networks leads to lots of trouble

Hmm…mistakes in health care data? Who’d have imagined that. Which leads to lots of politics in the setting up and creation of these “high-performing networks” and of course the ability for the baby of improvement to be thrown out with the bathwater of data incompetence, if poorly introduced.

What am I talking about? Well you’ll have to read Jeremy Smerd at Workforce.com on what went wrong when Regence tried to introduce a high-performance network for Boeing. And then too about how Group Health of Puget Sound Puget Sound Health Alliance did it in a rather kindler, gentler and less lawsuit attracting way.

It’s in the end the employers’ fault. There the ones who told their plans to back off from doing this when costs were (apparently) under control in the 1990s. So the plans gave up on limiting their networks, and as a partial consequence, costs went up, and then the cycle starts again. Of course, the same thing will be true for the whole P4P movement.

POLICY/QUALITY/HOSPITALS: Keynsian reporting trumps Smith-ian invisibilty

Michael Cannon at Cato picks up on David Leonhardt’s NYT article about error/process reporting in hospitals and suggests that there’s no need for regulation, as the market is getting us there already.

Hmm… methinks Michael underestimates what one economist he does approve of suggests identifies as a major problem. People of the same trade seldom meet together, even for merriment and diversion, but the conversation ends in a conspiracy against the public, or in some contrivance to raise prices” He may think that this has only been going on since 2002 or thereabouts but Codman was trying and failing to get transparency in hospitals in 1910! If we’re going to wait for the industry to really do this by itself to respond to Smith’s invisible hand, then as an economist Michael probably doesn’t have quite such a high regard for once said, in the long run, we are all dead!. Codman certainly has been pushing up daisies for a more than 60 years.

POLICY/QUALITY: Why does Health Care in the USA cost so much? Over-utilization is an important factor by Walter Bradley

Walter Bradley has not only written the shorter piece today, but has sent me a longer piece citing over-utilization as a cause of high health care costs in the US. I’m inclined to agree with him even if Anderson doesn’t. It’s a longer more academic piece and I’ve buried most of it behind the fold.

Introduction

The United States (US) invests a higher proportion of gross domestic product (GDP) on health care than all other developed countries, despite which the US population suffers poorer access, a higher individual financial burden, inefficient care and a higher medical error rate than people in most other developed countries.

Continue reading…

PODCAST/CONSUMERS/TECH: HealthFacts

BCBS of Minnesota has set up an interesting approach to transparency and measuring provider performance. They’ve created a site called HealthCareFacts.org for consumers to look at and compare provider details, set up a subsidiary called Consumer Aware to run it, and are now marketing it to the world. The model is nutritional labeling. I met Amelia Schultz (the VP of Sales at Consumer Aware) and she set up this interview with founder and CEO MaryAnn Stump. (The interview was recorded on Feb 14, but posting was delayed because I had to fix some technical problems with it. All better now, I hope!)

assetto corsa mods